Bone substitutes - Biomaterials - Bioceramics
SMART BIOMATERIALS
With the launch of the Graftys® BCP, biphasic ceramic, the company is taking a share in the market for synthetic bone substitutes. This initial range presents technical characteristics that meet specific market requirements (porous architecture, mechanical resistance) and represents a first step towards building a complete and powerful product offer.
The filing of the patent for for resorbable bioactive cement confirms Graftys’ intention to grapple with unresolved market needs. In view of its higher mechanical resistance, its quick and controlled setting time and optimal resorption, the Graftys cement clearly contrasts with its competitors.
The company’s desire to innovate is illustrated by the progressive development of combination technologies involving the association of bone substitutes (calcium phosphate, cement) and active molecules. Such intelligent bone substitutes are mixed medical devices allowing local delivery of active principles to osteoarticular tissues (pain relievers, antibiotics, and bisphosphonates, for instance).
With the acquisition of rights on patents regarding biological regeneration of cartilage and intervertebral discs and the prevention of osteoporotic fractures, Graftys is actively collaborating with French academic research (INSERM, CNRS) to promote its patents worldwide.
By developing therapeutic solutions designed to combat major pathologies such as arthrosis, osteoporosis and pain (which are leading themes of the Bone and Joint Decade), Graftys partakes of the logic to reduce public health costs.
Bone substitutes - Biomaterials - Bioceramics
GRAFTYS - Eiffel Park - Bâtiment D - 415, rue Claude Nicolas Ledoux
Pôle d'Activités d'Aix en Provence - 13 854 AIX EN PROVENCE Cedex 3
Tel : + 33 (0)4 42 60 30 00 - Fax : + 33 (0)4 42 60 30 11